More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study.
Sascha StänderEnno SchmidtDetlef ZillikensRalf J LudwigKhalaf KridinPublished in: American journal of clinical dermatology (2021)
DPP4i-associated BP is characterized by a more severe blistering and erosive presentation despite lower levels of typically pathogenic antibodies.
Keyphrases